Press Releases

 
Press Releases
  Date Title View
Feb 9, 2016
ALBANY, N.Y., Feb. 9, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year 2015 financial results before the opening of the market on Wednesday, February 17, 2016.  Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET. The c...
Feb 4, 2016
ALBANY, N.Y., Feb. 4, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that Anthony J. Maddaluna, Executive Vice President of Pfizer Inc. and President of Pfizer Global Supply, has been elected to the AMRI Board of Directors, effective as of February 4, 2016. In addition, the Company announced that Mr. Gabe Leung, a director and member of t...
Jan 20, 2016
ALBANY, N.Y., Jan. 20, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that Dawn M. Von Rohr, will join AMRI as Sr. Vice President, API, effective January 25, 2016. Ms. Von Rohr will report to George Svokos, Chief Operating Officer, and will be a member of the executive team led by President and Chief Executive Officer, William Marth.  Ms....
Jan 14, 2016
BUFFALO, N.Y., Jan. 14, 2016 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that it has signed a collaboration agreement with the New York Center for Nanomedicine Research (NYCNMR) to co-market their nanotechnology services to global pharmaceutical and biotechnology clients. As part of the three-year agreement...
Jan 12, 2016
ALBANY, N.Y., Jan. 12, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) is pleased to announce the extension of a key insourcing relationship with a major pharmaceutical company designed to accelerate their chemistry and drug discovery efforts. The original insourcing collaboration, which commenced in 2011, is being extended significantly beyond its origin...
Jan 11, 2016
WOODCLIFF LAKE, N.J. & ALBANY, N.Y.--(BUSINESS WIRE)-- Eagle Pharmaceuticals ("Eagle" or the "Company") (NASDAQ:EGRX) and AMRI (NASDAQ:AMRI) today announced that they have entered into an agreement to jointly develop and manufacture several select and complex parenteral drug products for registration and subseque...
Jan 11, 2016
ALBANY, N.Y., Jan. 11, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced that Docetaxel Injection (non-alcohol formula) has been approved for commercial manufacture at its Burlington, Mass. aseptic fill-and-finish facility following U.S. Food and Drug Administration's (FDA) pre-approval inspection for this drug product. Eagle Pharmaceutical...
Jan 10, 2016
ALBANY, N.Y., Jan. 10, 2016 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the 34th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2016 at 8:00 a.m. PT, with a question and answer session to follow at 8:30 a.m. PT....
Jan 7, 2016
BUFFALO, N.Y. and DURHAM, N.C., Jan. 7, 2016 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) and Icagen, Inc. announced today that they have signed a collaboration agreement to co-market Icagen's ion channel and transporter technology to global pharmaceutical and biotechnology clients. As part of the three-year agreement, AMRI...
Jan 4, 2016
ALBANY, N.Y., Jan. 4, 2016 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the 34th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2016 at 7:30 a.m. PT, with a question and answer session to follow at 8:00 a.m. PT. A...
Page:
1
... NextLast
= add release to Briefcase